Biocon Biologics
Prabhakar Thota is an experienced professional in the biopharma industry, currently serving as Director at Biocon Biologics since June 2022. Prior to this role, Prabhakar held the position of Head QCA at Shilpa Biologics Pvt Ltd from May 2019 to June 2022 and served as Sr. Manager at Hetero Biopharma from June 2018 to May 2019, focusing on QC Analyticals. Experience also includes a tenure as Senior Manager at Biological E. LTD, where responsibilities included stability studies, validations, and technology transfer from November 2014 to June 2018. Prabhakar's early career includes roles as Quality Control Manager at Reliance Life Sciences and Quality Control personnel at Artemis Biotech. Prabhakar holds an MSc in Chemistry from Andhra University, completed between 2001 and 2003.
This person is not in any teams
This person is not in any offices
Biocon Biologics
8 followers
Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like United States, EU, Australia, Canada and Japan. With a team of ~ 4,800 people, Biocon Biologics is committed to transforming healthcare and transforming lives by enabling affordable access to millions of patients’ worldwide. Follow-us on Twitter: @BioconBiologics